These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome. Tuteja AK; Talley NJ; Stoddard GJ; Verne GN Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492 [TBL] [Abstract][Full Text] [Related]
23. Serum Tryptophan Metabolite Levels During Sleep in Patients With and Without Irritable Bowel Syndrome (IBS). Heitkemper MM; Han CJ; Jarrett ME; Gu H; Djukovic D; Shulman RJ; Raftery D; Henderson WA; Cain KC Biol Res Nurs; 2016 Mar; 18(2):193-8. PubMed ID: 26156003 [TBL] [Abstract][Full Text] [Related]
24. Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults. Kemppinen A; Howell C; Allgar V; Dodd M; Gregson J; Knowles C; McLaughlin J; Pandya P; Whorwell P; Markaryan E; Yiannakou Y Trials; 2020 Jan; 21(1):122. PubMed ID: 32000822 [TBL] [Abstract][Full Text] [Related]
26. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426 [TBL] [Abstract][Full Text] [Related]
27. The effects of sildenafil on rectal sensitivity and tone in patients with the irritable bowel syndrome. Gonçalves de Medeiros MT; de Oliveira RB; dos Santos AA; de Leopoldino DM; Lima MC; Nobre RA; Nobre e Souza MÂ Aliment Pharmacol Ther; 2012 Mar; 35(5):577-86. PubMed ID: 22229478 [TBL] [Abstract][Full Text] [Related]
28. Abdominal Pain and Depression, Not Bowel Habits, Predict Health Care Utilization in Patients With Functional Bowel Disorders. Yu V; Ballou S; Hassan R; Singh P; Shah E; Rangan V; Iturrino J; Nee J; Lembo A Am J Gastroenterol; 2021 Aug; 116(8):1720-1726. PubMed ID: 34003175 [TBL] [Abstract][Full Text] [Related]
29. Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study. Tuteja AK; Fang JC; Al-Suqi M; Stoddard GJ; Hale DC Scand J Gastroenterol; 2012 Oct; 47(10):1159-64. PubMed ID: 22783919 [TBL] [Abstract][Full Text] [Related]
30. Decoding IBS: a machine learning approach to psychological distress and gut-brain interaction. Lundervold AJ; Billing JE; Berentsen B; Lied GA; Steinsvik EK; Hausken T; Lundervold A BMC Gastroenterol; 2024 Aug; 24(1):267. PubMed ID: 39148020 [TBL] [Abstract][Full Text] [Related]
31. Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. Lembo A; Pimentel M; Rao SS; Schoenfeld P; Cash B; Weinstock LB; Paterson C; Bortey E; Forbes WP Gastroenterology; 2016 Dec; 151(6):1113-1121. PubMed ID: 27528177 [TBL] [Abstract][Full Text] [Related]
32. Rectal hypersensitivity reduced by acupoint TENS in patients with diarrhea-predominant irritable bowel syndrome: a pilot study. Xiao WB; Liu YL Dig Dis Sci; 2004 Feb; 49(2):312-9. PubMed ID: 15104377 [TBL] [Abstract][Full Text] [Related]
33. The impact of transcutaneous electrical acustimulation (TEA) on rectal distension-induced pain in patients with irritable bowel syndrome (IBS)-A study to determine the optimal TEA delivery modalities and effects on rectal sensation and autonomic function. Nojkov B; Burnett C; Watts L; Yin J; Ali K; Zhao T; Gong S; Miller C; Habrowski M; Chey WD; Chen JDZ Neurogastroenterol Motil; 2024 Jul; 36(7):e14799. PubMed ID: 38671591 [TBL] [Abstract][Full Text] [Related]
34. Effect of long-term treatment with octreotide on rectal sensitivity in patients with non-constipated irritable bowel syndrome. Klooker TK; Kuiken SD; Lei A; Boeckxstaens GE Aliment Pharmacol Ther; 2007 Aug; 26(4):605-15. PubMed ID: 17661764 [TBL] [Abstract][Full Text] [Related]
35. Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome. Houghton LA; Fell C; Whorwell PJ; Jones I; Sudworth DP; Gale JD Gut; 2007 Sep; 56(9):1218-25. PubMed ID: 17446306 [TBL] [Abstract][Full Text] [Related]
36. Sleep disturbances in irritable bowel syndrome: a systematic review. Tu Q; Heitkemper MM; Jarrett ME; Buchanan DT Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 27683238 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of the Combination of Pinaverium Bromide 100 mg Plus Simethicone 300 mg in Abdominal Pain and Bloating in Irritable Bowel Syndrome: A Randomized, Placebo-controlled Trial. Schmulson MJ; Chiu-Ugalde J; Sáez-Ríos A; López-Colombo A; Mateos-Pérez GJ; Remes-Troche JM; Sobrino-Cossio S; Soto-Pérez JC; Tamayo de la Cuesta JL; Teramoto-Matsubara OT; López-Alvarenga JC J Clin Gastroenterol; 2020 Apr; 54(4):e30-e39. PubMed ID: 31385885 [TBL] [Abstract][Full Text] [Related]
38. Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea. Lembo A; Rao SSC; Heimanson Z; Pimentel M Clin Transl Gastroenterol; 2020 Mar; 11(3):e00144. PubMed ID: 32352714 [TBL] [Abstract][Full Text] [Related]
39. Rifaximin therapy for patients with irritable bowel syndrome without constipation. Pimentel M; Lembo A; Chey WD; Zakko S; Ringel Y; Yu J; Mareya SM; Shaw AL; Bortey E; Forbes WP; N Engl J Med; 2011 Jan; 364(1):22-32. PubMed ID: 21208106 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial. Xu H; Zhang C; Qian Y; Zou J; Li X; Liu Y; Zhu H; Meng L; Liu S; Zhang W; Yi H; Guan J; Chen Z; Yin S Sleep Med; 2020 Dec; 76():113-119. PubMed ID: 33157425 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]